{"id":55092,"date":"2026-01-22T09:43:36","date_gmt":"2026-01-22T01:43:36","guid":{"rendered":"https:\/\/flcube.com\/?p=55092"},"modified":"2026-01-22T09:43:37","modified_gmt":"2026-01-22T01:43:37","slug":"hangzhou-diagens-biotechnology-files-hkex-ipo-for-medical-imaging-ai-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55092","title":{"rendered":"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform"},"content":{"rendered":"\n<p><strong>Hangzhou Diagens Biotechnology Co., Ltd.<\/strong> announced a <strong>filing for an initial public offering (IPO)<\/strong> to the <strong>Hong Kong Stock Exchange<\/strong>, seeking to raise capital to advance its <strong>medical imaging AI platform<\/strong> and diversify its product portfolio across software, devices, and consumables.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Hangzhou Diagens Biotechnology Co., Ltd.<\/td><\/tr><tr><td><strong>Event<\/strong><\/td><td>Initial Public Offering (IPO) filing<\/td><\/tr><tr><td><strong>Exchange<\/strong><\/td><td>Hong Kong Stock Exchange<\/td><\/tr><tr><td><strong>Founded<\/strong><\/td><td>2016<\/td><\/tr><tr><td><strong>Business Focus<\/strong><\/td><td>Medical imaging artificial intelligence (AI) solutions<\/td><\/tr><tr><td><strong>Filing Date<\/strong><\/td><td>Week of 13\u202fJan\u202f2026<\/td><\/tr><tr><td><strong>Use of Proceeds<\/strong><\/td><td>R&amp;D, commercialization, technology licensing expansion<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-company-profile-amp-product-portfolio\">Company Profile &amp; Product Portfolio<\/h2>\n\n\n\n<p><strong>Core Offerings:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Medical Imaging Software (6 products):<\/strong><\/li>\n\n\n\n<li><strong>AI AutoVision<\/strong> \u2013 Flagship product, currently in <strong>registration stage<\/strong><\/li>\n\n\n\n<li><strong>AutoVision<\/strong> \u2013 <strong>Commercialized<\/strong> product generating revenue<\/li>\n\n\n\n<li><strong>4 candidate products<\/strong> in <strong>preclinical stage<\/strong><\/li>\n\n\n\n<li><strong>Medical Devices (3 products):<\/strong> <strong>Commercialized<\/strong> imaging hardware<\/li>\n\n\n\n<li><strong>Reagents &amp; Consumables (4 categories):<\/strong> Supporting diagnostic workflows<\/li>\n\n\n\n<li><strong>Technology Licensing:<\/strong> Services provided to <strong>medical institutions, academic research organizations, and regional healthcare entities<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Innovation:<\/strong> <strong>AI\u2011driven diagnostic efficiency<\/strong> and <strong>service quality enhancement<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-opportunity-amp-competitive-landscape\">Market Opportunity &amp; Competitive Landscape<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>China Medical Imaging AI Market<\/th><th>Global Market<\/th><\/tr><\/thead><tbody><tr><td><strong>Market Size (2026E)<\/strong><\/td><td>\u00a528\u202fbillion ($4.0\u202fbillion)<\/td><td>$12.5\u202fbillion<\/td><\/tr><tr><td><strong>Growth Rate<\/strong><\/td><td>24% CAGR<\/td><td>19% CAGR<\/td><\/tr><tr><td><strong>Penetration Rate<\/strong><\/td><td>18%<\/td><td>35%<\/td><\/tr><tr><td><strong>Key Drivers<\/strong><\/td><td>Radiologist shortage, diagnostic accuracy needs, AI policy support<\/td><td><\/td><\/tr><tr><td><strong>Diagens Peak Share (2030E)<\/strong><\/td><td>3%<\/td><td>1%<\/td><\/tr><tr><td><strong>Peak Revenue (2032E)<\/strong><\/td><td>\u00a5850\u202fmillion<\/td><td>$125\u202fmillion<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><strong>Key Competitors:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Infervision<\/strong> \u2013 Market leader in lung AI diagnostics<\/li>\n\n\n\n<li><strong>Deepwise<\/strong> \u2013 Diversified imaging AI portfolio<\/li>\n\n\n\n<li><strong>Yitu Healthcare<\/strong> \u2013 Strong government partnerships<\/li>\n\n\n\n<li><strong>Diagens<\/strong> \u2013 <strong>Differentiated<\/strong> by <strong>integrated software\u2011device\u2011reagent ecosystem<\/strong> and <strong>licensing revenue model<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-positioning-amp-next-steps\">Strategic Positioning &amp; Next Steps<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Advantage:<\/strong> <strong>AI AutoVision registration<\/strong> represents <strong>first\u2011in\u2011class<\/strong> ophthalmology AI diagnostic in China<\/li>\n\n\n\n<li><strong>Commercial Model:<\/strong> <strong>Dual revenue streams<\/strong> \u2013 direct product sales + <strong>technology licensing<\/strong> diversifies risk<\/li>\n\n\n\n<li><strong>Manufacturing:<\/strong> <strong>Self\u2011owned production lines<\/strong> for devices and reagents reduce supply chain dependency<\/li>\n\n\n\n<li><strong>Global Expansion:<\/strong> IPO proceeds will fund <strong>CE marking<\/strong> (targeted Q4\u202f2026) and <strong>FDA 510(k) filings<\/strong> (2027)<\/li>\n\n\n\n<li><strong>Pipeline:<\/strong> Preclinical software candidates target <strong>neurology and cardiology<\/strong>, expanding beyond ophthalmology<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding IPO completion, market penetration, and revenue forecasts. Actual results may differ due to regulatory review timelines, competitive dynamics, and market adoption rates for AI diagnostics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/sehk26010602100_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of sehk26010602100_c.\"><\/object><a id=\"wp-block-file--media-5c7fc8fc-7a3c-429f-9a5b-d3cd59a6f0fa\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/sehk26010602100_c.pdf\">sehk26010602100_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/sehk26010602100_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-5c7fc8fc-7a3c-429f-9a5b-d3cd59a6f0fa\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Hangzhou Diagens Biotechnology Co., Ltd. announced a filing for an initial public offering (IPO) to&#8230;<\/p>\n","protected":false},"author":1,"featured_media":55094,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4187,72],"class_list":["post-55092","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-diagens-biotechnology","tag-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Hangzhou Diagens Biotechnology Co., Ltd. announced a filing for an initial public offering (IPO) to the Hong Kong Stock Exchange, seeking to raise capital to advance its medical imaging AI platform and diversify its product portfolio across software, devices, and consumables.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55092\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform\" \/>\n<meta property=\"og:description\" content=\"Hangzhou Diagens Biotechnology Co., Ltd. announced a filing for an initial public offering (IPO) to the Hong Kong Stock Exchange, seeking to raise capital to advance its medical imaging AI platform and diversify its product portfolio across software, devices, and consumables.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55092\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-22T01:43:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T01:43:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2201.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform\",\"datePublished\":\"2026-01-22T01:43:36+00:00\",\"dateModified\":\"2026-01-22T01:43:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092\"},\"wordCount\":348,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2201.webp\",\"keywords\":[\"Diagens Biotechnology\",\"IPO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55092#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55092\",\"name\":\"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2201.webp\",\"datePublished\":\"2026-01-22T01:43:36+00:00\",\"dateModified\":\"2026-01-22T01:43:37+00:00\",\"description\":\"Hangzhou Diagens Biotechnology Co., Ltd. announced a filing for an initial public offering (IPO) to the Hong Kong Stock Exchange, seeking to raise capital to advance its medical imaging AI platform and diversify its product portfolio across software, devices, and consumables.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55092\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2201.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/2201.webp\",\"width\":1080,\"height\":608,\"caption\":\"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55092#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform - Insight, China&#039;s Pharmaceutical Industry","description":"Hangzhou Diagens Biotechnology Co., Ltd. announced a filing for an initial public offering (IPO) to the Hong Kong Stock Exchange, seeking to raise capital to advance its medical imaging AI platform and diversify its product portfolio across software, devices, and consumables.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55092","og_locale":"en_US","og_type":"article","og_title":"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform","og_description":"Hangzhou Diagens Biotechnology Co., Ltd. announced a filing for an initial public offering (IPO) to the Hong Kong Stock Exchange, seeking to raise capital to advance its medical imaging AI platform and diversify its product portfolio across software, devices, and consumables.","og_url":"https:\/\/flcube.com\/?p=55092","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-22T01:43:36+00:00","article_modified_time":"2026-01-22T01:43:37+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2201.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55092#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55092"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform","datePublished":"2026-01-22T01:43:36+00:00","dateModified":"2026-01-22T01:43:37+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55092"},"wordCount":348,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=55092#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2201.webp","keywords":["Diagens Biotechnology","IPO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55092#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55092","url":"https:\/\/flcube.com\/?p=55092","name":"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=55092#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=55092#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2201.webp","datePublished":"2026-01-22T01:43:36+00:00","dateModified":"2026-01-22T01:43:37+00:00","description":"Hangzhou Diagens Biotechnology Co., Ltd. announced a filing for an initial public offering (IPO) to the Hong Kong Stock Exchange, seeking to raise capital to advance its medical imaging AI platform and diversify its product portfolio across software, devices, and consumables.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55092#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55092"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=55092#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2201.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2201.webp","width":1080,"height":608,"caption":"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55092#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Hangzhou Diagens Biotechnology Files HKEX IPO for Medical Imaging AI Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/2201.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55092"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55092\/revisions"}],"predecessor-version":[{"id":55095,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55092\/revisions\/55095"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/55094"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}